By expenditures
| Name | Title | Type |
|---|---|---|
| Gerald Sanzari | Executive Director | Auditee |
| Tom Furlong | Fee Accountant | Auditee |
| Rich Larsen | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 352015 | 2024 | 2025-03-31 | Novogradac & Company LLP | $15.09M |
| 300576 | 2023 | 2024-03-29 | Novogradac & Company LLP | $13.89M |
| 29717 | 2022 | 2023-03-27 | Novogradac & Company LLP | $14.74M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 352015 | 2024 | 2025-03-31 | 1127526 | 2024-002 | Significant Deficiency | - | B |
| 352015 | 2024 | 2025-03-31 | 1127525 | 2024-003 | Material Weakness | - | N |
| 352015 | 2024 | 2025-03-31 | 1127524 | 2024-003 | Material Weakness | - | N |
| 352015 | 2024 | 2025-03-31 | 1127523 | 2024-002 | Significant Deficiency | - | B |
| 352015 | 2024 | 2025-03-31 | 551084 | 2024-002 | Significant Deficiency | - | B |
| 352015 | 2024 | 2025-03-31 | 551083 | 2024-003 | Material Weakness | - | N |
| 352015 | 2024 | 2025-03-31 | 551082 | 2024-003 | Material Weakness | - | N |
| 352015 | 2024 | 2025-03-31 | 551081 | 2024-002 | Significant Deficiency | - | B |